C12N 2770/38034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/38034 (Use of virus or viral component as vaccine) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 5
- Inventors
- 32
- Latest grant
- 11 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 2 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Artificial viral capsid19 Feb 2026US 2026/0049107 A1AGC Inc.
- Vaccines formed by virus and antigen conjugation5 Aug 2021US 2021/0236624 A1Kentucky BioProcessing, Inc.
- Vaccines formed by virus and antigen conjugation7 Jan 2021US 2021/0000942 A1Kentucky BioProcessing, Inc.
- Civet animal model system for Severe Acute Respiratory Syndrome (SARS) coronavirus infection and uses thereof8 Jun 2006US 2006/0123499 A1
Most cited
By later US patents